Vireo Growth (VREOF) Inventory (2020 - 2026)
Vireo Growth (VREOF) reported Inventory of $76.1 million for Q1 2026, up 226.0% on a YoY basis from $23.3 million in Q1 2025, and up 26.83% sequentially from $60.0 million in Q4 2025.
Vireo Growth (VREOF) Inventory (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Inventory data on file, last reported at $76.1 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 226.0% year-over-year to $76.1 million; the trailing twelve-month figure through Mar 2026 stood at $76.1 million (up 226.0% YoY), and the FY2025 full-year result was $60.0 million, up 176.93% from the prior year.
- Inventory rose to $76.1 million in Q1 2026, from $60.0 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $76.1 million in Q1 2026 to a low of $18.3 million in Q1 2022.
- A 5-year average of $30.2 million and a median of $20.1 million in 2024 frame the typical range for Inventory.
- Across the five-year window, Inventory retreated 11.42% in 2024 and jumped 226.0% in 2026, its largest moves.
- Tracing VREOF's Inventory over 5 years: stood at $20.5 million in 2022, then dropped by 5.96% to $19.3 million in 2023, then climbed by 12.34% to $21.7 million in 2024, then surged by 176.93% to $60.0 million in 2025, then gained by 26.83% to $76.1 million in 2026.
- Business Quant data shows VREOF's Inventory at $76.1 million in Q1 2026, $60.0 million in Q4 2025, and $53.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.36 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.55 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 178.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.49 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.72 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 76.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.10 Mn |
| Dec 31, 2025 | 60.00 Mn |
| Sep 30, 2025 | 53.90 Mn |
| Jun 30, 2025 | 63.03 Mn |
| Mar 31, 2025 | 23.34 Mn |
| Dec 31, 2024 | 21.67 Mn |
| Sep 30, 2024 | 19.85 Mn |
| Jun 30, 2024 | 20.09 Mn |
| Mar 31, 2024 | 19.36 Mn |
| Dec 31, 2023 | 19.29 Mn |
| Sep 30, 2023 | 19.06 Mn |
| Jun 30, 2023 | 19.78 Mn |
| Mar 31, 2023 | 21.85 Mn |
| Dec 31, 2022 | 20.51 Mn |
| Sep 30, 2022 | 19.11 Mn |
| Jun 30, 2022 | 18.61 Mn |
| Mar 31, 2022 | 18.26 Mn |
| Dec 31, 2021 | 20.42 Mn |
| Sep 30, 2021 | 20.14 Mn |
| Jun 30, 2021 | 16.73 Mn |